ENANTA PHARMACEUTICALS INC (ENTA) › Operating Cash FlowENANTA PHARMACEUTICALS INC (ENTA) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2011: $24.02M2012: $22.62M2013: $10.65M2016: $35.81M2017: $52.65M2018: $29.22M2019: $71.42M2020: $7.09M2021: -$70.00M2022: -$84.78M2023: -$103.15M2024: -$78.76M2025: -$19.27M-$19.27M2011Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$19.27M+75.5%2024-$78.76M+23.6%2023-$103.15M-21.7%2022-$84.78M-21.1%2021-$70.00M-1087.5%2020$7.09M-90.1%2019$71.42M+144.4%2018$29.22M-44.5%2017$52.65M+47.0%2016$35.81M—2013$10.65M-52.9%2012$22.62M-5.8%2011$24.02M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share